Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12200169 | 0.74 | NOS3 (0.43) | CYP11B1CYP11B2 | |
| SCHEMBL1695679 | 0.74 | CYP11B1 (0.33) | CYP11B1CYP11B2 | |
| SCHEMBL18907842 | 0.73 | CYP11B1 (0.33) | CYP11B1CYP11B2GABRA1GABRB1 | |
| SCHEMBL19228468 | 0.70 | CYP11B1 (0.31) | CYP11B1CYP11B2 | |
| SCHEMBL18084624 | 0.70 | ALDH1A1 (0.35) | CYP11B1CYP11B2 | |
| SCHEMBL15999359 | 0.70 | KDM4E (0.32) | CYP11B1CYP11B2 | |
| SCHEMBL12890923 | 0.70 | CYP11B1 (0.31) | CYP11B1CYP11B2 | |
| SCHEMBL20445171 | 0.70 | CYP11B1 (0.31) | CYP11B1CYP11B2 | |
| SCHEMBL12777853 | 0.69 | — | — | |
| SCHEMBL23015715 | 0.68 | ALDH1A1 (0.31) | CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012138797-A1 | 3- OR 5 - BI PHENYL - 4 - YLISOXAZOLE - BASED COMPOUNDS USEFUL FOR THE TREATMENT OF FIBROSIS, PAIN, CANCER AND RESPIRATORY, ALLERGIC, NERVOUS SYSTEM OR CARDIOVASCULAR DISORDERS | AMIRA PHARMACEUTICALS, INC. (US) | 2012-10-11 | — | — | WO | disclosed |
| WO-2011041461-A2 | POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | AMIRA PHARMACEUTICALS, INC. (US) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011041462-A2 | POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | AMIRA PHARMACEUTICALS, INC. (US) | 2011-04-07 | — | — | WO | disclosed |